% | $
Quotes you view appear here for quick access.


  • kelmahon kelmahon Jan 9, 2007 10:01 AM Flag

    ACTC, Wake Forest p-ship coming!

    After some digging I have reason to believe that a formal partnership between ACTC and Wake Forests Dept. of Regenerative Medicine will be announced soon. ACTC would not only being a key player in the arena of ESCs but stem cells derived from amniotic fluid as well thanks to a licensing agreement. I still have some additional light digging to do, which would serve as a confirmation, but that may be precluded by an announcment from company officials.

    This would have a profound effect on the stock price!!!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Robert Lanza (VP of Research at ACT) has collaborated with Dr. Atala at Wake Forest for years (beginning when he was at Childrens Hospital in Boston); so it would not be a surprise.

      This stock is easily moved by press releases and related stem cell news. Unfortunately, the quick sell offs indicate high speculation and less expectation of long-term potential. Hopefully the capital markets will not push it around too much before they can get a clinical trial and focused cell-based product going, either by themselves or in partnership with another company.